Defibrillator News and Research

Latest Defibrillator News and Research

Cameron Health completes enrollment in subcutaneous implantable defibrillator pivotal study

Cameron Health, Inc. announced today that it has completed enrollment in its pivotal FDA clinical study of the S-ICD System, the world's only completely subcutaneous implantable defibrillator.

5 May 2011

First implantation of WiCS wireless cardiac pacing system performed in Germany

EBR Systems, Inc., a privately held clinical stage company, announced today the first human implants of the WiCS Wireless Cardiac Stimulation System.

3 May 2011

WAST NHS to equip its frontline ambulances with ZOLL E Series EMS monitor/defibrillator

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Welsh Ambulance Services NHS is equipping its frontline ambulances with the ZOLL E Series EMS monitor/defibrillator.

30 Apr 2011

ZOLL Medical second quarter revenues increase 14% to $122.5 million

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, today announced that revenues for the second quarter of fiscal 2011 increased 14% to $122.5 million, compared to revenues in the second quarter of last year of $107.1 million.

28 Apr 2011

FDA approves BIOTRONIK's new Estella and Effecta pacemakers

BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced FDA approval of the new Estella and Effecta pacemakers, as well as advanced new features and technologies for the Evia pacemaker family.

28 Apr 2011

Cardiac Science receives European contract for automated external defibrillator

The wholly-owned subsidiary of Opto Circuits Ltd., Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, has been awarded a contract to deploy 650 Powerheart AEDs in Girona, Spain, home to 700,000 Catalonians.

27 Apr 2011

Spectranetics revenue increases 5% to $30.4 million for first quarter 2011

Spectranetics Corporation today reported financial results for the quarter ended March 31, 2011.

27 Apr 2011

Canada Prime Minister announces $10 million fund for defibrillators and related training

Today Prime Minister Stephen Harper announced a $10 million plan to fund life-saving automated external defibrillators and related training in hockey arenas and community recreation centres across Canada.

22 Apr 2011

Experts question hospital's heart device data claims

The New York Times: Medical Experts Dispute A Hospital's Claims On Heart Device Data.

22 Apr 2011

First Edition: April 21, 2011

In today's news, reports about President Barack Obama's Facebook visit during which he stepped up his criticism of GOP plans to overhaul Medicare and Medicaid but said he expects to strike a deal to reduce the deficit.

21 Apr 2011

Forest acquires worldwide rights to novel antiarrhythmic agent azimilide

Forest Laboratories, Inc. today announced that its wholly-owned subsidiary Forest Laboratories Holdings Limited and Blue Ash Therapeutics, LLC have entered into an asset purchase agreement, pursuant to which Forest has acquired worldwide rights to azimilide, a novel antiarrhythmic agent originally developed by Procter & Gamble Pharmaceuticals.

20 Apr 2011

Japanese MHLW approves Spectranetics LLD lead locking device

Spectranetics Corporation today announced that the Japanese Ministry of Health, Labor and Welfare granted approval for the LLD lead locking device, which is used for the removal of pacemaker and defibrillator cardiac leads.

6 Apr 2011

ICD therapy can improve ischemic cardiomyopathy survival rates

Most patients with ischemic cardiomyopathy and dilated cardiomyopathy who have an implantable cardioverter-defibrillator now live more than seven years and those ICD patients with hereditary heart disease can live for decades, based on a scientific paper that will be presented at the American College of Cardiology Scientific Sessions in New Orleans, April 1-3.

6 Apr 2011

Heart patients share perspectives on deactivation, donation and reuse of ICD devices

Each year, more than 100,000 patients in the U.S. undergo implantation of a new implantable cardioverter defibrillator (ICD) for heart rhythm abnormalities. This number constitutes a 20-fold increase over the last 15 years. Current medical guidelines advocate discussion of end of life care of these medical devices, including deactivation, but many patients may not understand their options.

6 Apr 2011

Adherence to guideline-related therapies can reduce heart failure patients' mortality rate

A UCLA-led study has found that adherence to national guideline-recommended therapies for heart failure in an outpatient practice setting significantly lowered the mortality rate of heart failure patients.

5 Apr 2011

FDA approves Medtronic's Protecta implantable defibrillators

Medtronic, Inc. today announced U.S. Food and Drug Administration approval of the Protecta portfolio of implantable cardioverter-defibrillators and cardiac resynchronization therapy-defibrillators.

29 Mar 2011

FDA approves Medtronic's Consulta and Syncra pacemaker systems

Medtronic, Inc. today announced that the U.S. Food & Drug Administration has approved its Consulta and Syncra cardiac resynchronization therapy-pacemaker systems.

25 Mar 2011

NSW selects ZOLL AED Plus devices for Rural Fire Service stations

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has received an award from the Government of NSW Australia to provide 5450 AED Plus devices for installation on all Rural Fire Service stations deployed throughout the State of New South Wales.

10 Mar 2011

State roundup: Mass. effort to manage care for chronically ill; promoting organ donations

For a glimpse of the future of Massachusetts health care as Gov. Deval Patrick envisions it, consider Phyllis Minsky. At 82, Phyllis is complex. Medically, that is. ... Older patients with multiple chronic diseases are the biggest consumers of health care; some 15 percent of Medicare patients make up over 75 percent of health care spending.

8 Mar 2011

CRT-D therapy benefits heart failure patients with left bundle branch block

Mild heart failure patients with a particular condition that results in disorganized electrical activity throughout the heart benefit substantially from cardiac resynchronization therapy with defibrillator (CRT-D), according to a study published in the American Heart Association journal Circulation.

2 Mar 2011